Nearly seven years after its finalization by the ICH Assembly in November 2019, ICH Q12 (Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management) has officially moved from a forward-looking conceptual framework to an operational regulatory expectation.
With the FDA advancing its implementation, the EU clearing legal pathways through Regulation (EU) 2024/1701,...